论文部分内容阅读
2000年10月14日,中国加入WTO的双边市场准入谈判进程基本结束,多边加入程序也已经启动。在中国与其他各国所达成的双边协议,特别是中美两国签署的有关中国加入WTO的协议中,中国承诺不迟于2003年1月1日允许外资在中国市场从事药品零售业务条款(简称“开放药品分销服务条款”)引起我国药品销售企业极大的关注。因为这一条款将对我国医药流通业产生巨大的影响。1开放药品分销服务条款的激励效应:蜂拥而至的外企开放药品分销服务条款下,必然激励国外的大批发商、
On October 14, 2000, the negotiation process of bilateral market access for China's accession to the WTO basically ended and the process of multilateral accession has also started. In the agreements reached between China and other countries, especially the agreements signed by China and the United States on China's accession to the WTO, China promised not to allow foreign investors to engage in the pharmaceutical retail business in the Chinese market no later than January 1, 2003 “Open Drug Distribution Terms of Service ”) aroused great concern in China's pharmaceutical sales companies. Because of this clause will have a huge impact on China's pharmaceutical distribution industry. Incentive effects of the provision of an open pharmaceutical distribution service: The fledgling foreign-invested pharmaceutical products under the terms of the distribution service will inevitably motivate foreign wholesalers,